Related references
Note: Only part of the references are listed.The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
John A. Spertus et al.
NATURE MEDICINE (2022)
Operationalizing Virtual Trials in Oncology-From Aspiration to Action
Kushal T. Kadakia et al.
JCO CLINICAL CANCER INFORMATICS (2021)
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
Antoinette R. Tan et al.
LANCET ONCOLOGY (2021)
The Growing Phenomenon of Virtual-First Primary Care
David C. Whitehead et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Novel Trial Design: CHIEF-HF
John A. Spertus et al.
CIRCULATION-HEART FAILURE (2021)
Evaluation of Oncology Hospital at Home: Unplanned Health Care Utilization and Costs in the Huntsman at Home Real-World Trial
Kathi Mooney et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Digital Health Navigation: An Enabling Infrastructure for Optimizing and Integrating Virtual Care Into Oncology Practice comment
Anaeze C. Offodile et al.
JCO CLINICAL CANCER INFORMATICS (2021)
Alpha-T: An innovative decentralized (home-based) phase 2 trial of alectinib in ALK-positive (ALK plus ) solid tumors in a histology-agnostic setting.
Razelle Kurzrock et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial
Rachel L. Randell et al.
LUPUS SCIENCE & MEDICINE (2021)
Virtual Clinical Trials: Perspectives in Dermatology
Zarqa Ali et al.
DERMATOLOGY (2020)
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
Hannelore Denys et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
US Physician and Nurse Proclivity to Refer Their Patients Into Clinical Trials
Kenneth A. Getz
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2020)
Outpatient Treatment at Home for Medicare Beneficiaries During and After the COVID-19 Pandemic
Justin E. Bekelman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in Oncology
Christine M. Parseghian et al.
JAMA ONCOLOGY (2019)
The Impact of Hospital Characteristics on the Availability of Radiology Services at Critical Access Hospitals
Amir A. Khaliq et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2015)
Clinical trial discussion, referral, and recruitment: physician, patient, and system factors
Celia P. Kaplan et al.
CANCER CAUSES & CONTROL (2013)
Engaging Referring Physicians in the Clinical Trial Process
Allison R. Baer et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Availability and quality of computed tomography and magnetic resonance imaging equipment in US emergency departments
Adit A. Ginde et al.
ACADEMIC EMERGENCY MEDICINE (2008)